BIO Integration
出版商：Compuscript, Ltd. · ISSN：2712-0074, 2712-0082 · 国家/地区：IE · 类型：journal · OA 开放获取
研究主题：Nanoplatforms for cancer theranostics · Ultrasound and Hyperthermia Applications · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Biomedical and Engineering Education
数据覆盖：7 个公开学术数据源交叉核验（crossref、doaj、openalex、scimago、wikidata、cwts、jufo）。
数据来源与实体核验
核心指标
- SJR:0.859(Q1)，2025 年，Ireland
- CWTS 2025:SNIP 0.678 · IPP 4.587 · 自引率 0.9%
- JUFO 出版渠道等级:芬兰 0
- h-index:22
- i10 指数:46
- 近两年篇均被引:5.68
- 载文量 208 · 总被引 1703
- Crossref DOI 总量:208，近期 110
逐年趋势
- 近年 SJR:2023 0.435(Q3) → 2024 0.303(Q3) → 2025 0.859(Q1)
投稿参考
- DOAJ 收录的开放获取期刊,不收取文章处理费(APC)
常见问题
《BIO Integration》是开放获取(OA)期刊吗?
是,《BIO Integration》是开放获取(Open Access)期刊,已被 DOAJ 收录。
《BIO Integration》收版面费吗?
根据 DOAJ 收录信息,《BIO Integration》不收取文章处理费(APC)。
本刊近期代表论文
- A Proof-of-Concept Comparison of Azure Kinect and Smartphone-based OpenCap for Driving Musculoskeletal Simulations: A Unified Framework with Foot-Ground Contact Modeling (2026 · 被引 1)
- Multiscale End-point Screening with Extended Tight-binding Hamiltonians (2025 · 被引 6)
- Understanding Vascular Toxicity of Indigo Naturalis in Anti-Inflammatory Applications: Mendelian Randomization and Co-localization Study (2025 · 被引 3)
- Contrast-Enhanced Ultrasound Features of Primary Hepatic Lymphoepithelioma-Like Carcinoma: Comparison with Hepatocellular Carcinoma (2024 · 被引 5)
- The metabolite 2-Methylbutyrylcarnitine does not Promote Atherosclerosis in Apolipoprotein E-Deficient Mice (2024 · 被引 4)
- Single-Cell RNA-Sequencing Integration Analysis Revealed Immune Cell Heterogeneity in Five Human Autoimmune Diseases (2023 · 被引 28)